|
2025-01-02 |
2025-01-02 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
1,373
-1.3%
155.48
USD 213,474
|
1,373
-1.3%
|
155.48
|
USD 213,474
|
|
|
2024-12-06 |
2024-12-06 |
S
Sale
|
Woolson Daniel
VP, GM-Infusion Capital
Officer
|
2,241
-17.1%
156.25
USD 350,158
|
2,241
-17.1%
|
156.25
|
USD 350,158
|
|
|
2024-12-02 |
2024-12-02 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
78
-0.1%
163.96
USD 12,789
|
78
-0.1%
|
163.96
|
USD 12,789
|
|
|
2024-12-02 |
2024-12-02 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
8,250
-7.3%
163.18
USD 1,346,223
|
8,250
-7.3%
|
163.18
|
USD 1,346,223
|
|
|
2024-12-02 |
2024-12-02 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
3,672
-3.1%
162.29
USD 595,923
|
3,672
-3.1%
|
162.29
|
USD 595,923
|
|
|
2024-11-27 |
2024-11-27 |
S
Sale
|
Greenberg David C.
Non-Executive Director
|
972
-16.2%
158.11
USD 153,683
|
972
-16.2%
|
158.11
|
USD 153,683
|
|
|
2024-11-27 |
2024-11-27 |
S
Sale
|
Voigtlander Christian B.
Chief Operating Officer
Officer
|
1,430
-100.0%
158.00
USD 225,936
|
1,430
-100.0%
|
158.00
|
USD 225,936
|
|
|
2024-11-26 |
2024-11-26 |
S
Sale
|
Voigtlander Christian B.
Chief Operating Officer
Officer
|
206
-100.0%
160.09
USD 32,979
|
206
-100.0%
|
160.09
|
USD 32,979
|
|
|
2024-11-26 |
2024-11-26 |
S
Sale
|
Voigtlander Christian B.
Chief Operating Officer
Officer
|
7,513
-97.3%
159.09
USD 1,195,212
|
7,513
-97.3%
|
159.09
|
USD 1,195,212
|
|
|
2024-11-26 |
2024-11-25 |
S
Sale
|
Voigtlander Christian B.
Chief Operating Officer
Officer
|
1,962
-100.0%
169.08
USD 331,726
|
1,962
-100.0%
|
169.08
|
USD 331,726
|
|
|
2024-11-04 |
2024-11-01 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
1,239
-1.2%
173.60
USD 215,087
|
1,239
-1.2%
|
173.60
|
USD 215,087
|
|
|
2024-11-04 |
2024-11-01 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
2,386
-2.2%
172.76
USD 412,212
|
2,386
-2.2%
|
172.76
|
USD 412,212
|
|
|
2024-11-04 |
2024-11-01 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
4,147
-3.7%
171.91
USD 712,905
|
4,147
-3.7%
|
171.91
|
USD 712,905
|
|
|
2024-11-04 |
2024-11-01 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
4,228
-3.6%
170.75
USD 721,933
|
4,228
-3.6%
|
170.75
|
USD 721,933
|
|
|
2024-10-01 |
2024-10-01 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
788
-0.7%
180.48
USD 142,219
|
788
-0.7%
|
180.48
|
USD 142,219
|
|
|
2024-10-01 |
2024-10-01 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
3,375
-3.1%
179.16
USD 604,658
|
3,375
-3.1%
|
179.16
|
USD 604,658
|
|
|
2024-10-01 |
2024-10-01 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
3,681
-3.3%
178.49
USD 657,021
|
3,681
-3.3%
|
178.49
|
USD 657,021
|
|
|
2024-10-01 |
2024-10-01 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
4,156
-3.6%
177.50
USD 737,682
|
4,156
-3.6%
|
177.50
|
USD 737,682
|
|
|
2024-09-03 |
2024-09-03 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
3,805
-3.5%
164.07
USD 624,298
|
3,805
-3.5%
|
164.07
|
USD 624,298
|
|
|
2024-09-03 |
2024-09-03 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
4,440
-4.1%
163.59
USD 726,326
|
4,440
-4.1%
|
163.59
|
USD 726,326
|
|
|
2024-09-03 |
2024-09-03 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
3,755
-3.5%
162.69
USD 610,916
|
3,755
-3.5%
|
162.69
|
USD 610,916
|
|
|
2024-08-30 |
2024-08-30 |
S
Sale
|
Woolson Daniel
VP, GM-Infusion Capital
Officer
|
2,502
-16.0%
163.22
USD 408,370
|
2,502
-16.0%
|
163.22
|
USD 408,370
|
|
|
2024-08-16 |
2024-08-16 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
12,000
-10.3%
156.04
USD 1,872,480
|
12,000
-10.3%
|
156.04
|
USD 1,872,480
|
|
|
2024-08-08 |
2024-08-08 |
PS
Planned sale
|
Sanzone Virginia Ruth
VP, General Counsel
Officer
|
2,050
-31.4%
144.11
USD 295,426
|
2,050
-31.4%
|
144.11
|
USD 295,426
|
|
|
2024-05-30 |
2024-05-30 |
S
Sale
|
Voigtlander Christian B.
Chief Operating Officer
Officer
|
2,032
-100.0%
104.49
USD 212,328
|
2,032
-100.0%
|
104.49
|
USD 212,328
|
|
|
2024-05-30 |
2024-05-30 |
S
Sale
|
Voigtlander Christian B.
Chief Operating Officer
Officer
|
10,507
-83.8%
103.85
USD 1,091,156
|
10,507
-83.8%
|
103.85
|
USD 1,091,156
|
|
|
2024-05-16 |
2024-05-16 |
S
Sale
|
FINNEY ELISHA W
Non-Executive Director
|
300
-12.4%
104.95
USD 31,484
|
300
-12.4%
|
104.95
|
USD 31,484
|
|
|
2024-05-10 |
2024-05-10 |
S
Sale
|
Sousa Ben
Chief Information Officer
Officer
|
2,000
-60.3%
105.55
USD 211,090
|
2,000
-60.3%
|
105.55
|
USD 211,090
|
|
|
2024-03-15 |
2024-03-15 |
S
Sale
|
Woolson Daniel
VP, GM-Infusion Capital
Officer
|
791
-5.4%
98.27
USD 77,733
|
791
-5.4%
|
98.27
|
USD 77,733
|
|
|
2024-03-14 |
2024-03-14 |
S
Sale
|
LOPEZ GEORGE A
Non-Executive Director
|
7,978
-0.9%
101.87
USD 812,741
|
7,978
-0.9%
|
101.87
|
USD 812,741
|
|
|
2024-03-13 |
2024-03-12 |
S
Sale
|
LOPEZ GEORGE A
Non-Executive Director
|
1,522
-0.5%
101.51
USD 154,497
|
1,522
-0.5%
|
101.51
|
USD 154,497
|
|
|
2024-03-13 |
2024-03-11 |
S
Sale
|
LOPEZ GEORGE A
Non-Executive Director
|
1,890
-0.6%
104.22
USD 196,968
|
1,890
-0.6%
|
104.22
|
USD 196,968
|
|
|
2024-03-11 |
2024-03-08 |
S
Sale
|
Sanzone Virginia Ruth
VP, General Counsel
Officer
|
3,300
-40.9%
104.57
USD 345,088
|
3,300
-40.9%
|
104.57
|
USD 345,088
|
|
|
2024-03-11 |
2024-03-08 |
S
Sale
|
LOPEZ GEORGE A
Non-Executive Director
|
15,372
-4.6%
105.94
USD 1,628,454
|
15,372
-4.6%
|
105.94
|
USD 1,628,454
|
|
|
2024-03-11 |
2024-03-07 |
S
Sale
|
LOPEZ GEORGE A
Non-Executive Director
|
18,954
-5.4%
105.77
USD 2,004,708
|
18,954
-5.4%
|
105.77
|
USD 2,004,708
|
|
|
2024-03-11 |
2024-03-04 |
S
Sale
|
LOPEZ GEORGE A
Non-Executive Director
|
7,051
-2.0%
106.79
USD 752,993
|
7,051
-2.0%
|
106.79
|
USD 752,993
|
|
|
2024-03-05 |
2024-03-04 |
S
Sale
|
Voigtlander Christian B.
Chief Operating Officer
Officer
|
219
-100.0%
108.30
USD 23,717
|
219
-100.0%
|
108.30
|
USD 23,717
|
|
|
2024-03-05 |
2024-03-04 |
S
Sale
|
Voigtlander Christian B.
Chief Operating Officer
Officer
|
6,497
-96.7%
107.60
USD 699,060
|
6,497
-96.7%
|
107.60
|
USD 699,060
|
|
|
2024-03-05 |
2024-03-04 |
S
Sale
|
Voigtlander Christian B.
Chief Operating Officer
Officer
|
6,887
-50.6%
106.77
USD 735,314
|
6,887
-50.6%
|
106.77
|
USD 735,314
|
|
|
2024-03-01 |
2024-02-29 |
S
Sale
|
SMITHS GROUP PLC
|
830,000
-33.2%
106.08
USD 88,042,250
|
830,000
-33.2%
|
106.08
|
USD 88,042,250
|
|
|
2024-03-01 |
2024-02-29 |
S
Sale
|
Smiths Group International Holdings Ltd
|
830,000
-33.2%
106.08
USD 88,042,250
|
830,000
-33.2%
|
106.08
|
USD 88,042,250
|
|
|
2023-12-01 |
2023-12-01 |
S
Sale
|
Woolson Daniel
VP, GM-Infusion Capital
Officer
|
1,729
-14.9%
88.03
USD 152,196
|
1,729
-14.9%
|
88.03
|
USD 152,196
|
|
|
2023-09-11 |
2023-09-08 |
S
Sale
|
Voigtlander Christian B.
Chief Operating Officer
Officer
|
688
-4.8%
129.64
USD 89,195
|
688
-4.8%
|
129.64
|
USD 89,195
|
|
|
2023-09-11 |
2023-09-08 |
S
Sale
|
Voigtlander Christian B.
Chief Operating Officer
Officer
|
6,162
-30.1%
128.97
USD 794,735
|
6,162
-30.1%
|
128.97
|
USD 794,735
|
|
|
2023-07-14 |
2023-07-12 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
30,000
-55.9%
180.02
USD 5,400,720
|
30,000
-55.9%
|
180.02
|
USD 5,400,720
|
|
|
2023-06-15 |
2023-06-14 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
2,104
-8.2%
193.30
USD 406,695
|
2,104
-8.2%
|
193.30
|
USD 406,695
|
|
|
2023-06-15 |
2023-06-14 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
100
-0.4%
194.73
USD 19,473
|
100
-0.4%
|
194.73
|
USD 19,473
|
|
|
2023-06-15 |
2023-06-14 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
2,418
-8.6%
194.02
USD 469,145
|
2,418
-8.6%
|
194.02
|
USD 469,145
|
|
|
2023-06-15 |
2023-06-14 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
1,601
-6.3%
192.06
USD 307,490
|
1,601
-6.3%
|
192.06
|
USD 307,490
|
|
|
2023-06-15 |
2023-06-14 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
1,699
-6.7%
190.48
USD 323,629
|
1,699
-6.7%
|
190.48
|
USD 323,629
|
|
|
2023-06-15 |
2023-06-14 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
785
-3.2%
189.32
USD 148,614
|
785
-3.2%
|
189.32
|
USD 148,614
|
|
|
2023-06-15 |
2023-06-14 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
8,163
-25.6%
188.52
USD 1,538,852
|
8,163
-25.6%
|
188.52
|
USD 1,538,852
|
|
|
2023-06-15 |
2023-06-14 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
2,781
-10.5%
187.43
USD 521,254
|
2,781
-10.5%
|
187.43
|
USD 521,254
|
|
|
2023-06-15 |
2023-06-14 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
3,637
-13.3%
186.50
USD 678,311
|
3,637
-13.3%
|
186.50
|
USD 678,311
|
|
|
2023-06-15 |
2023-06-14 |
S
Sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
6,712
-22.1%
185.73
USD 1,246,623
|
6,712
-22.1%
|
185.73
|
USD 1,246,623
|
|
|
2023-06-07 |
2023-06-07 |
PS
Planned sale
|
FINNEY ELISHA W
Non-Executive Director
|
194
-11.6%
190.41
USD 36,940
|
194
-11.6%
|
190.41
|
USD 36,940
|
|
|
2023-04-11 |
2023-04-11 |
PS
Planned sale
|
Sanzone Virginia Ruth
VP, General Counsel
Officer
|
250
-5.1%
175.00
USD 43,750
|
250
-5.1%
|
175.00
|
USD 43,750
|
|
|
2023-04-05 |
2023-04-05 |
PS
Planned sale
|
Sanzone Virginia Ruth
VP, General Counsel
Officer
|
458
-8.5%
170.00
USD 77,860
|
458
-8.5%
|
170.00
|
USD 77,860
|
|
|
2023-02-02 |
2023-02-02 |
PS
Planned sale
|
Woolson Daniel
VP, GM-Infusion Capital
Officer
|
1,731
-15.9%
200.00
USD 346,200
|
1,731
-15.9%
|
200.00
|
USD 346,200
|
|
|
2022-11-15 |
2022-11-15 |
PS
Planned sale
|
Sanzone Virginia Ruth
VP, General Counsel
Officer
|
325
-9.6%
160.12
USD 52,039
|
325
-9.6%
|
160.12
|
USD 52,039
|
|
|
2022-05-13 |
2022-05-12 |
B
Purchase
|
LOPEZ GEORGE A
Non-Executive Director
|
17
+0.0%
174.66
USD 2,969
|
17
+0.0%
|
174.66
|
USD 2,969
|
|
|
2022-05-13 |
2022-05-12 |
B
Purchase
|
LOPEZ GEORGE A
Non-Executive Director
|
9,329
+3.4%
174.17
USD 1,624,838
|
9,329
+3.4%
|
174.17
|
USD 1,624,838
|
|
|
2022-05-13 |
2022-05-12 |
B
Purchase
|
LOPEZ GEORGE A
Non-Executive Director
|
7,092
+2.7%
173.07
USD 1,227,444
|
7,092
+2.7%
|
173.07
|
USD 1,227,444
|
|
|
2022-05-13 |
2022-05-12 |
B
Purchase
|
LOPEZ GEORGE A
Non-Executive Director
|
4,917
+1.9%
172.24
USD 846,885
|
4,917
+1.9%
|
172.24
|
USD 846,885
|
|
|
2022-05-13 |
2022-05-12 |
B
Purchase
|
LOPEZ GEORGE A
Non-Executive Director
|
4,480
+1.8%
170.79
USD 765,119
|
4,480
+1.8%
|
170.79
|
USD 765,119
|
|
|
2022-05-12 |
2022-05-12 |
PS
Planned sale
|
FINNEY ELISHA W
Non-Executive Director
|
217
-10.1%
170.53
USD 37,005
|
217
-10.1%
|
170.53
|
USD 37,005
|
|
|
2022-05-12 |
2022-05-12 |
S
Sale
|
Sanzone Virginia Ruth
VP, General Counsel
Officer
|
750
-18.2%
173.56
USD 130,170
|
750
-18.2%
|
173.56
|
USD 130,170
|
|
|
2022-03-04 |
2022-03-03 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
36,000
-73.8%
240.00
USD 8,640,000
|
36,000
-73.8%
|
240.00
|
USD 8,640,000
|
|
|
2021-11-05 |
2021-11-03 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
12,000
-48.4%
240.00
USD 2,880,046
|
12,000
-48.4%
|
240.00
|
USD 2,880,046
|
|
|
2021-11-05 |
2021-11-03 |
PS
Planned sale
|
Jain Vivek
Chairman and CEO
Executive Director
|
12,000
-48.4%
240.00
USD 2,880,000
|
12,000
-48.4%
|
240.00
|
USD 2,880,000
|
|
|
2021-09-14 |
2021-09-14 |
S
Sale
|
FINNEY ELISHA W
Non-Executive Director
|
2,424
-58.5%
242.20
USD 587,096
|
2,424
-58.5%
|
242.20
|
USD 587,096
|
|
|
2021-09-13 |
2021-09-10 |
S
Sale
|
Sanzone Virginia Ruth
VP, General Counsel
Officer
|
248
-13.4%
252.82
USD 62,698
|
248
-13.4%
|
252.82
|
USD 62,698
|
|
|
2021-09-13 |
2021-09-10 |
S
Sale
|
Sanzone Virginia Ruth
VP, General Counsel
Officer
|
401
-17.8%
251.27
USD 100,757
|
401
-17.8%
|
251.27
|
USD 100,757
|
|
|
2021-09-13 |
2021-09-10 |
S
Sale
|
Sanzone Virginia Ruth
VP, General Counsel
Officer
|
151
-6.3%
250.23
USD 37,785
|
151
-6.3%
|
250.23
|
USD 37,785
|
|
|
2021-06-03 |
2021-06-03 |
S
Sale
|
SWINNEY ROBERT S
Non-Executive Director
|
207
-0.9%
204.04
USD 42,236
|
207
-0.9%
|
204.04
|
USD 42,236
|
|
